Comprehensive assessment of the management of acute cholecystitis in Scotland: population-wide cohort study.
Journal
BJS open
ISSN: 2474-9842
Titre abrégé: BJS Open
Pays: England
ID NLM: 101722685
Informations de publication
Date de publication:
03 07 2023
03 07 2023
Historique:
received:
17
05
2023
accepted:
08
06
2023
medline:
15
8
2023
pubmed:
14
8
2023
entrez:
14
8
2023
Statut:
ppublish
Résumé
Acute cholecystitis is one of the most common diagnoses presenting to emergency general surgery and is managed either operatively or conservatively. However, operative rates vary widely across the world. This real-world population analysis aimed to describe the current clinical management and outcomes of patients with acute cholecystitis across Scotland, UK. This was a national cohort study using data obtained from Information Services Division, Scotland. All adult patients with the admission diagnostic code for acute cholecystitis were included. Data were used to identify all patients admitted to Scottish hospitals between 1997 and 2019 and outcomes tracked for inpatients or after discharge through the unique patient identifier. This was linked to death data, including date of death. A total of 47 558 patients were diagnosed with 58 824 episodes of acute cholecystitis (with 27.2 per cent of patients experiencing more than one episode) in 46 Scottish hospitals. Median age was 58 years (interquartile range (i.q.r.) 43-71), 64.4 per cent were female, and most (76.1 per cent) had no comorbidities. A total of 28 741 (60.4 per cent) patients had an operative intervention during the index admission. Patients who had an operation during their index admission had a lower risk of 90-day mortality compared with non-operative management (OR 0.62, 95% c.i. 0.55-0.70). In this study, 60 per cent of patients had an index cholecystectomy. Patients who underwent surgery had a better survival rate compared with those managed conservatively, further advocating for an operative approach in this cohort.
Sections du résumé
BACKGROUND
Acute cholecystitis is one of the most common diagnoses presenting to emergency general surgery and is managed either operatively or conservatively. However, operative rates vary widely across the world. This real-world population analysis aimed to describe the current clinical management and outcomes of patients with acute cholecystitis across Scotland, UK.
METHODS
This was a national cohort study using data obtained from Information Services Division, Scotland. All adult patients with the admission diagnostic code for acute cholecystitis were included. Data were used to identify all patients admitted to Scottish hospitals between 1997 and 2019 and outcomes tracked for inpatients or after discharge through the unique patient identifier. This was linked to death data, including date of death.
RESULTS
A total of 47 558 patients were diagnosed with 58 824 episodes of acute cholecystitis (with 27.2 per cent of patients experiencing more than one episode) in 46 Scottish hospitals. Median age was 58 years (interquartile range (i.q.r.) 43-71), 64.4 per cent were female, and most (76.1 per cent) had no comorbidities. A total of 28 741 (60.4 per cent) patients had an operative intervention during the index admission. Patients who had an operation during their index admission had a lower risk of 90-day mortality compared with non-operative management (OR 0.62, 95% c.i. 0.55-0.70).
CONCLUSION
In this study, 60 per cent of patients had an index cholecystectomy. Patients who underwent surgery had a better survival rate compared with those managed conservatively, further advocating for an operative approach in this cohort.
Identifiants
pubmed: 37578027
pii: 7242187
doi: 10.1093/bjsopen/zrad073
pmc: PMC10424165
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of BJS Society Ltd.
Références
J Hepatobiliary Pancreat Surg. 2007;14(1):15-26
pubmed: 17252293
JAMA Netw Open. 2022 Aug 1;5(8):e2229247
pubmed: 36040737
Hepatogastroenterology. 2001 Sep-Oct;48(41):1275-8
pubmed: 11677945
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
HPB (Oxford). 2015 Mar;17(3):239-43
pubmed: 25363135
BMJ. 2018 Oct 8;363:k3965
pubmed: 30297544
J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):55-72
pubmed: 29045062
JAMA. 2022 Mar 8;327(10):965-975
pubmed: 35258527
J Trauma Acute Care Surg. 2021 Jun 1;90(6):996-1002
pubmed: 34016923
Health Technol Assess. 2014 Aug;18(55):1-101, v-vi
pubmed: 25164349
J Hepatobiliary Pancreat Sci. 2017 Jun;24(6):338-345
pubmed: 28419779
Postgrad Med J. 2004 May;80(943):292-4
pubmed: 15138321
Trauma Surg Acute Care Open. 2020 Jul 27;5(1):e000500
pubmed: 32789189
Surg Res Pract. 2019 Feb 03;2019:9709242
pubmed: 30854417
Scand J Surg. 2019 Jun;108(2):124-129
pubmed: 30227774
J Trauma Acute Care Surg. 2018 Sep;85(3):500-506
pubmed: 30020228
World J Emerg Surg. 2020 Nov 5;15(1):61
pubmed: 33153472
Ann Surg. 2021 Aug 1;274(2):367-374
pubmed: 31567508
Surg Endosc. 2017 Feb;31(2):504-515
pubmed: 27317033
Front Digit Health. 2022 Sep 15;4:845453
pubmed: 36339515
J Laparoendosc Adv Surg Tech A. 2013 Mar;23(3):220-4
pubmed: 23234333
Dig Surg. 2018;35(2):171-176
pubmed: 28704814
Arq Bras Cir Dig. 2017 Jan-Mar;30(1):47-50
pubmed: 28489169